$AXK Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Accelerate Diagnostics, Inc.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Accelerate Diagnostics, Inc. Get notifications about new insider transactions in Accelerate Diagnostics, Inc for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 24 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | M | 0.00 | 62,160 | 0 | 124,320 | |
Jun 24 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Sell | S | 7.94 | 23,479 | 186,423 | 112,698 | 136.2 K to 112.7 K (-17.24 %) |
Jun 24 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Buy | M | 0.00 | 62,160 | 0 | 136,177 | 74 K to 136.2 K (+83.98 %) |
May 24 2021 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Option Exercise | A | 7.68 | 35,168 | 270,090 | 35,168 | |
May 24 2021 | AXK | Accelerate Diagnos ... | FRANCESCONI LOUISE | Director | Option Exercise | A | 7.68 | 35,168 | 270,090 | 35,168 | |
May 24 2021 | AXK | Accelerate Diagnos ... | PATIENCE JOHN | Director | Option Exercise | A | 7.68 | 35,168 | 270,090 | 35,168 | |
May 14 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 0.00 | 27,392 | 0 | 0 | |
May 14 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 6.76 | 8,303 | 56,128 | 34,672 | 43 K to 34.7 K (-19.32 %) |
May 14 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 0.00 | 27,392 | 0 | 42,975 | 15.6 K to 43 K (+175.78 %) |
May 14 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Option Exercise | M | 0.00 | 19,335 | 0 | 0 | |
May 14 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Sell | S | 6.76 | 6,282 | 42,466 | 14,927 | 21.2 K to 14.9 K (-29.62 %) |
May 14 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Buy | M | 0.00 | 19,335 | 0 | 21,209 | 1.9 K to 21.2 K (+1,031.75 %) |
May 14 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | M | 0.00 | 79,893 | 0 | 0 | |
May 14 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Sell | S | 6.76 | 25,064 | 169,433 | 74,017 | 99.1 K to 74 K (-25.30 %) |
May 14 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Buy | M | 0.00 | 79,893 | 0 | 99,081 | 19.2 K to 99.1 K (+416.37 %) |
Apr 13 2021 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Grant | A | 7.68 | 19,531 | 149,998 | 187,297 | 167.8 K to 187.3 K (+11.64 %) |
Apr 13 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Grant | A | 7.68 | 4,340 | 33,331 | 19,188 | 14.8 K to 19.2 K (+29.23 %) |
Apr 13 2021 | AXK | Accelerate Diagnos ... | PATIENCE JOHN | Director | Grant | A | 7.68 | 21,701 | 166,664 | 4,343,883 | 4.3 M to 4.3 M (+0.50 %) |
Apr 13 2021 | AXK | Accelerate Diagnos ... | MILLER MARK C | Director | Grant | A | 7.68 | 13,020 | 99,994 | 26,040 | 13 K to 26 K (+100.00 %) |
Apr 13 2021 | AXK | Accelerate Diagnos ... | Brown Thomas D | Director | Grant | A | 7.68 | 8,680 | 66,662 | 37,860 | 29.2 K to 37.9 K (+29.75 %) |
Mar 16 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | A | 0.00 | 113,265 | 0 | 140,657 | |
Mar 16 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | A | 0.00 | 27,392 | 0 | 27,392 | |
Mar 16 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Option Exercise | A | 0.00 | 104,338 | 0 | 123,673 | |
Mar 16 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Option Exercise | A | 0.00 | 19,335 | 0 | 19,335 | |
Mar 16 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | A | 0.00 | 79,893 | 0 | 79,893 | |
Feb 24 2021 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Grant | A | 7.68 | 19,531 | 149,998 | 167,766 | 148.2 K to 167.8 K (+13.18 %) |
Feb 23 2021 | AXK | Accelerate Diagnos ... | PATIENCE JOHN | Director | Grant | A | 7.68 | 21,701 | 166,664 | 4,322,182 | 4.3 M to 4.3 M (+0.50 %) |
Feb 23 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | PRESIDENT AND CEO | Grant | A | 7.68 | 4,340 | 33,331 | 14,848 | 10.5 K to 14.8 K (+41.30 %) |
Feb 23 2021 | AXK | Accelerate Diagnos ... | Brown Thomas D | Director | Grant | A | 7.68 | 8,680 | 66,662 | 29,180 | 20.5 K to 29.2 K (+42.34 %) |
Feb 23 2021 | AXK | Accelerate Diagnos ... | MILLER MARK C | Director | Grant | A | 7.68 | 13,020 | 99,994 | 13,020 | 0 to 13 K |
Feb 04 2021 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | J | 9.87 | 54,132 | 534,283 | 1,262,023 | 1.2 M to 1.3 M (+4.48 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,142 | 0 | 0 | |
Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 7.37 | 859 | 6,331 | 15,583 | 16.4 K to 15.6 K (-5.22 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 0.00 | 3,142 | 0 | 16,442 | 13.3 K to 16.4 K (+23.62 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 0.00 | 3,142 | 0 | 0 | |
Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 7.37 | 859 | 6,331 | 15,583 | 16.4 K to 15.6 K (-5.22 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 0.00 | 3,142 | 0 | 16,442 | 13.3 K to 16.4 K (+23.62 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Option Exercise | M | 0.00 | 2,601 | 0 | 0 | |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Sell | S | 7.37 | 727 | 5,358 | 1,874 | 2.6 K to 1.9 K (-27.95 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Buy | M | 0.00 | 2,601 | 0 | 2,601 | 0 to 2.6 K |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Option Exercise | M | 0.00 | 2,601 | 0 | 0 | |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Sell | S | 7.37 | 727 | 5,358 | 1,874 | 2.6 K to 1.9 K (-27.95 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Buy | M | 0.00 | 2,601 | 0 | 2,601 | 0 to 2.6 K |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | M | 0.00 | 10,000 | 0 | 40,000 | |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Sell | S | 10.90 | 3,313 | 36,112 | 10,508 | 13.8 K to 10.5 K (-23.97 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Buy | M | 0.00 | 10,000 | 0 | 13,821 | 3.8 K to 13.8 K (+261.71 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | M | 0.00 | 10,000 | 0 | 40,000 | |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Sell | S | 10.90 | 3,313 | 36,112 | 10,508 | 13.8 K to 10.5 K (-23.97 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Buy | M | 0.00 | 10,000 | 0 | 13,821 | 3.8 K to 13.8 K (+261.71 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,363 | 0 | 0 | |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Sell | S | 7.37 | 1,542 | 11,365 | 3,821 | 5.4 K to 3.8 K (-28.75 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Buy | M | 0.00 | 5,363 | 0 | 5,363 | 0 to 5.4 K |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | M | 0.00 | 5,363 | 0 | 0 | |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Sell | S | 7.37 | 1,542 | 11,365 | 3,821 | 5.4 K to 3.8 K (-28.75 %) |
Feb 03 2021 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Buy | M | 0.00 | 5,363 | 0 | 5,363 | 0 to 5.4 K |
Feb 03 2021 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | J | 11.40 | 100,000 | 1,140,000 | 1,207,891 | 1.1 M to 1.2 M (+9.03 %) |
Feb 02 2021 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 10.18 | 30,868 | 314,236 | 1,107,891 | 1.1 M to 1.1 M (+2.87 %) |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 2.98 | 25,000 | 74,500 | 50,000 | |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 2.98 | 24,910 | 74,232 | 75,000 | |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 2.98 | 20,761 | 61,868 | 99,910 | |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 15.25 | 25,000 | 381,250 | 13,300 | 38.3 K to 13.3 K (-65.27 %) |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 2.98 | 25,000 | 74,500 | 38,300 | 13.3 K to 38.3 K (+187.97 %) |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 12.50 | 24,910 | 311,375 | 13,300 | 38.2 K to 13.3 K (-65.19 %) |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 2.98 | 24,910 | 74,232 | 38,210 | 13.3 K to 38.2 K (+187.29 %) |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 10.55 | 20,761 | 219,029 | 13,300 | 34.1 K to 13.3 K (-60.95 %) |
Jan 27 2021 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 2.98 | 20,761 | 61,868 | 34,061 | 13.3 K to 34.1 K (+156.10 %) |
Nov 12 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 2.98 | 39,329 | 117,200 | 120,671 | |
Nov 12 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Sell | S | 9.50 | 39,329 | 373,626 | 13,300 | 52.6 K to 13.3 K (-74.73 %) |
Nov 12 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 2.98 | 39,329 | 117,200 | 52,629 | 13.3 K to 52.6 K (+295.71 %) |
Aug 28 2020 | AXK | Accelerate Diagnos ... | SAFWAT NEDAL | Chief Strategy Offi ... | Option Exercise | A | 14.51 | 39,769 | 577,048 | 139,769 | |
Aug 28 2020 | AXK | Accelerate Diagnos ... | SAFWAT NEDAL | Chief Strategy Offi ... | Option Exercise | A | 14.51 | 100,000 | 1,451,000 | 100,000 | |
Aug 28 2020 | AXK | Accelerate Diagnos ... | SAFWAT NEDAL | Chief Strategy Offi ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Jul 01 2020 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Option Exercise | A | 0.00 | 2,601 | 0 | 2,601 | |
Jul 01 2020 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | A | 0.00 | 5,363 | 0 | 5,363 | |
Jul 01 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | A | 0.00 | 3,142 | 0 | 3,142 | |
Jun 24 2020 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | A | 0.00 | 186,480 | 0 | 186,480 | |
Jun 22 2020 | AXK | Accelerate Diagnos ... | HUMPHRIES ROMNEY | Chief Scientific Of ... | Option Exercise | M | 5.93 | 3,000 | 17,790 | 7,864 | |
Jun 22 2020 | AXK | Accelerate Diagnos ... | HUMPHRIES ROMNEY | Chief Scientific Of ... | Option Exercise | M | 5.93 | 2,000 | 11,860 | 10,864 | |
Jun 22 2020 | AXK | Accelerate Diagnos ... | HUMPHRIES ROMNEY | Chief Scientific Of ... | Option Exercise | M | 5.93 | 4,000 | 23,720 | 12,864 | |
Jun 22 2020 | AXK | Accelerate Diagnos ... | HUMPHRIES ROMNEY | Chief Scientific Of ... | Sell | S | 12.00 | 3,000 | 36,000 | 0 | 3 K to 0 (-100.00 %) |
Jun 22 2020 | AXK | Accelerate Diagnos ... | HUMPHRIES ROMNEY | Chief Scientific Of ... | Buy | M | 5.93 | 3,000 | 17,790 | 3,000 | 0 to 3 K |
Jun 22 2020 | AXK | Accelerate Diagnos ... | HUMPHRIES ROMNEY | Chief Scientific Of ... | Sell | S | 11.75 | 2,000 | 23,500 | 0 | 2 K to 0 (-100.00 %) |
Jun 22 2020 | AXK | Accelerate Diagnos ... | HUMPHRIES ROMNEY | Chief Scientific Of ... | Buy | M | 5.93 | 2,000 | 11,860 | 2,000 | 0 to 2 K |
Jun 22 2020 | AXK | Accelerate Diagnos ... | HUMPHRIES ROMNEY | Chief Scientific Of ... | Sell | S | 11.00 | 4,000 | 44,000 | 0 | 4 K to 0 (-100.00 %) |
Jun 22 2020 | AXK | Accelerate Diagnos ... | HUMPHRIES ROMNEY | Chief Scientific Of ... | Buy | M | 5.93 | 4,000 | 23,720 | 4,000 | 0 to 4 K |
Jun 17 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 9.86 | 95,492 | 941,551 | 16,603,524 | 16.5 M to 16.6 M (+0.58 %) |
Jun 16 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 9.34 | 134,080 | 1,252,307 | 16,508,032 | 16.4 M to 16.5 M (+0.82 %) |
Jun 15 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 9.18 | 129,000 | 1,184,220 | 16,373,952 | 16.2 M to 16.4 M (+0.79 %) |
Jun 12 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 9.84 | 100,000 | 984,000 | 16,244,952 | 16.1 M to 16.2 M (+0.62 %) |
Jun 11 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 9.63 | 180,955 | 1,742,597 | 16,144,952 | 16 M to 16.1 M (+1.13 %) |
Jun 09 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 8.58 | 1,100,000 | 9,438,000 | 15,963,997 | 14.9 M to 16 M (+7.40 %) |
Jun 09 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 8.58 | 1,100,000 | 9,438,000 | 15,963,997 | 14.9 M to 16 M (+7.40 %) |
May 15 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 9.46 | 89,055 | 842,460 | 14,863,997 | 14.8 M to 14.9 M (+0.60 %) |
May 14 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 9.92 | 20,000 | 198,400 | 14,774,942 | 14.8 M to 14.8 M (+0.14 %) |
May 13 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 9.99 | 20,000 | 199,800 | 14,754,942 | 14.7 M to 14.8 M (+0.14 %) |
May 11 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 9.87 | 25,000 | 246,750 | 14,734,942 | 14.7 M to 14.7 M (+0.17 %) |
May 08 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 10.00 | 10,868 | 108,680 | 14,709,942 | 14.7 M to 14.7 M (+0.07 %) |
May 06 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 9.98 | 1,204 | 12,016 | 14,690,449 | 14.7 M to 14.7 M (+0.01 %) |
May 05 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 10.03 | 4,000 | 40,120 | 14,689,245 | 14.7 M to 14.7 M (+0.03 %) |
Apr 28 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 10.00 | 5,001 | 50,010 | 14,685,245 | 14.7 M to 14.7 M (+0.03 %) |
Apr 27 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 9.90 | 81,621 | 808,048 | 14,680,244 | 14.6 M to 14.7 M (+0.56 %) |
Apr 24 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 9.47 | 157,688 | 1,493,305 | 14,598,623 | 14.4 M to 14.6 M (+1.09 %) |
Apr 23 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 9.01 | 79,650 | 717,647 | 14,440,935 | 14.4 M to 14.4 M (+0.55 %) |
Apr 22 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 9.40 | 59,357 | 557,956 | 14,361,285 | 14.3 M to 14.4 M (+0.42 %) |
Apr 14 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Gift | G | 0.00 | 1,100,000 | 0 | 1,077,023 | 2.2 M to 1.1 M (-50.53 %) |
Apr 03 2020 | AXK | Accelerate Diagnos ... | Watts Charles M | Director | Option Exercise | A | 8.33 | 13,779 | 114,779 | 13,779 | |
Apr 03 2020 | AXK | Accelerate Diagnos ... | TEN BRINK FRANK JM | Director | Option Exercise | A | 8.33 | 13,779 | 114,779 | 13,779 | |
Apr 03 2020 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Option Exercise | A | 8.33 | 13,779 | 114,779 | 13,779 | |
Apr 03 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Option Exercise | A | 8.33 | 13,779 | 114,779 | 13,779 | |
Apr 03 2020 | AXK | Accelerate Diagnos ... | PATIENCE JOHN | Director | Option Exercise | A | 8.33 | 13,779 | 114,779 | 13,779 | |
Apr 03 2020 | AXK | Accelerate Diagnos ... | MILLER MARK C | Director | Option Exercise | A | 8.33 | 13,779 | 114,779 | 13,779 | |
Apr 03 2020 | AXK | Accelerate Diagnos ... | FRANCESCONI LOUISE | Director | Option Exercise | A | 8.33 | 13,779 | 114,779 | 13,779 | |
Apr 03 2020 | AXK | Accelerate Diagnos ... | DIGGELMANN ROLAND D | Director | Option Exercise | A | 8.33 | 13,779 | 114,779 | 13,779 | |
Apr 03 2020 | AXK | Accelerate Diagnos ... | Brown Thomas D | Director | Option Exercise | A | 8.33 | 13,779 | 114,779 | 13,779 | |
Apr 02 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 8.30 | 120,000 | 996,000 | 14,301,928 | 14.2 M to 14.3 M (+0.85 %) |
Mar 31 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 8.09 | 101,963 | 824,881 | 14,101,928 | 14 M to 14.1 M (+0.73 %) |
Mar 30 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 8.04 | 148,037 | 1,190,217 | 13,999,965 | 13.9 M to 14 M (+1.07 %) |
Mar 27 2020 | AXK | Accelerate Diagnos ... | Watts Charles M | Director | Option Exercise | A | 21.02 | 12,290 | 258,336 | 12,290 | |
Mar 27 2020 | AXK | Accelerate Diagnos ... | TEN BRINK FRANK JM | Director | Option Exercise | A | 21.02 | 12,290 | 258,336 | 12,290 | |
Mar 27 2020 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Option Exercise | A | 21.02 | 12,290 | 258,336 | 12,290 | |
Mar 27 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Option Exercise | A | 21.02 | 12,290 | 258,336 | 12,290 | |
Mar 27 2020 | AXK | Accelerate Diagnos ... | PATIENCE JOHN | Director | Option Exercise | A | 21.02 | 12,290 | 258,336 | 12,290 | |
Mar 27 2020 | AXK | Accelerate Diagnos ... | MILLER MARK C | Director | Option Exercise | A | 21.02 | 12,290 | 258,336 | 12,290 | |
Mar 27 2020 | AXK | Accelerate Diagnos ... | Brown Thomas D | Director | Option Exercise | A | 21.02 | 12,290 | 258,336 | 12,290 | |
Mar 27 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | A | 16.90 | 12,634 | 213,515 | 12,634 | |
Mar 27 2020 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | A | 16.90 | 25,268 | 427,029 | 25,268 | |
Mar 27 2020 | AXK | Accelerate Diagnos ... | Phillips Jack | Chief Executive Off ... | Option Exercise | A | 0.00 | 50,000 | 0 | 50,000 | |
Mar 27 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 7.70 | 150,000 | 1,155,000 | 13,851,928 | 13.7 M to 13.9 M (+1.09 %) |
Mar 27 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 7.70 | 150,000 | 1,155,000 | 13,851,928 | 13.7 M to 13.9 M (+1.09 %) |
Mar 26 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | A | 5.93 | 67,061 | 397,672 | 67,061 | |
Mar 26 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | A | 5.93 | 20,118 | 119,300 | 20,118 | |
Mar 26 2020 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Option Exercise | A | 5.93 | 47,337 | 280,708 | 47,337 | |
Mar 26 2020 | AXK | Accelerate Diagnos ... | Price Ron | Head of Commercial ... | Option Exercise | A | 5.93 | 14,201 | 84,212 | 14,201 | |
Mar 26 2020 | AXK | Accelerate Diagnos ... | HUMPHRIES ROMNEY | Chief Scientific Of ... | Option Exercise | A | 5.93 | 56,213 | 333,343 | 56,213 | |
Mar 26 2020 | AXK | Accelerate Diagnos ... | HUMPHRIES ROMNEY | Chief Scientific Of ... | Option Exercise | A | 5.93 | 16,864 | 100,004 | 16,864 | |
Mar 26 2020 | AXK | Accelerate Diagnos ... | PATIENCE JOHN | Director | Buy | P | 6.83 | 5,000 | 34,150 | 4,196,211 | 4.2 M to 4.2 M (+0.12 %) |
Mar 26 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | J | 6.92 | 150,000 | 1,038,000 | 13,701,928 | 13.6 M to 13.7 M (+1.11 %) |
Mar 25 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | P | 5.89 | 172,900 | 1,018,381 | 13,551,928 | 13.4 M to 13.6 M (+1.29 %) |
Mar 20 2020 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Gift | G | 0.00 | 20,000 | 0 | 20,000 | 0 to 20 K |
Mar 20 2020 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Gift | G | 0.00 | 20,000 | 0 | 2,025,560 | 2 M to 2 M (-0.98 %) |
Mar 20 2020 | AXK | Accelerate Diagnos ... | Strobeck Matthew | Director | Buy | P | 7.11 | 10,000 | 71,100 | 148,235 | 138.2 K to 148.2 K (+7.23 %) |
Mar 02 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Option Exercise | M | 2.98 | 10,000 | 29,800 | 160,000 | |
Mar 02 2020 | AXK | Accelerate Diagnos ... | REICHLING STEVEN | Chief Financial Off ... | Buy | M | 2.98 | 10,000 | 29,800 | 12,300 | 2.3 K to 12.3 K (+434.78 %) |
Feb 27 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | J | 15.39 | 9,000 | 138,510 | 13,379,028 | 13.4 M to 13.4 M (+0.07 %) |
Feb 26 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Grant | A | 15.84 | 10,000 | 158,400 | 13,370,028 | 13.4 M to 13.4 M (+0.07 %) |
Feb 24 2020 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | J | 16.06 | 10,000 | 160,600 | 13,350,028 | 13.3 M to 13.4 M (+0.07 %) |
Dec 11 2019 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | J | 15.72 | 5,000 | 78,600 | 2,177,023 | 2.2 M to 2.2 M (+0.23 %) |
Dec 09 2019 | AXK | Accelerate Diagnos ... | SCHULER JACK W | Director | Buy | J | 15.94 | 5,000 | 79,700 | 2,172,023 | 2.2 M to 2.2 M (+0.23 %) |
Dec 04 2019 | AXK | Accelerate Diagnos ... | DIGGELMANN ROLAND D | Director | Option Exercise | A | 14.94 | 5,493 | 82,065 | 45,045 | |
Dec 04 2019 | AXK | Accelerate Diagnos ... | DIGGELMANN ROLAND D | Director | Option Exercise | A | 14.94 | 39,552 | 590,907 | 39,552 |